| pubmed-article:18949722 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18949722 | lifeskim:mentions | umls-concept:C0022646 | lld:lifeskim |
| pubmed-article:18949722 | lifeskim:mentions | umls-concept:C0035096 | lld:lifeskim |
| pubmed-article:18949722 | lifeskim:mentions | umls-concept:C0600688 | lld:lifeskim |
| pubmed-article:18949722 | lifeskim:mentions | umls-concept:C0332206 | lld:lifeskim |
| pubmed-article:18949722 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:18949722 | pubmed:dateCreated | 2008-10-24 | lld:pubmed |
| pubmed-article:18949722 | pubmed:abstractText | The influence of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) on contrast-induced renal toxicity has been poorly studied. Nevertheless, it is a common practice in many centers to stop these drugs before coronarography. Our goal was to study whether renal function was affected in patients taking ACEIs or ARBs and undergoing a coronary angiogram. | lld:pubmed |
| pubmed-article:18949722 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18949722 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18949722 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18949722 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18949722 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18949722 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18949722 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18949722 | pubmed:issn | 1121-8428 | lld:pubmed |
| pubmed-article:18949722 | pubmed:author | pubmed-author:FerailleEricE | lld:pubmed |
| pubmed-article:18949722 | pubmed:author | pubmed-author:MartinPierre-... | lld:pubmed |
| pubmed-article:18949722 | pubmed:author | pubmed-author:MachFrançoisF | lld:pubmed |
| pubmed-article:18949722 | pubmed:author | pubmed-author:SaudanPatrick... | lld:pubmed |
| pubmed-article:18949722 | pubmed:author | pubmed-author:MullerHajoH | lld:pubmed |
| pubmed-article:18949722 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:18949722 | pubmed:volume | 21 | lld:pubmed |
| pubmed-article:18949722 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18949722 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18949722 | pubmed:pagination | 681-5 | lld:pubmed |
| pubmed-article:18949722 | pubmed:meshHeading | pubmed-meshheading:18949722... | lld:pubmed |
| pubmed-article:18949722 | pubmed:meshHeading | pubmed-meshheading:18949722... | lld:pubmed |
| pubmed-article:18949722 | pubmed:meshHeading | pubmed-meshheading:18949722... | lld:pubmed |
| pubmed-article:18949722 | pubmed:meshHeading | pubmed-meshheading:18949722... | lld:pubmed |
| pubmed-article:18949722 | pubmed:meshHeading | pubmed-meshheading:18949722... | lld:pubmed |
| pubmed-article:18949722 | pubmed:meshHeading | pubmed-meshheading:18949722... | lld:pubmed |
| pubmed-article:18949722 | pubmed:meshHeading | pubmed-meshheading:18949722... | lld:pubmed |
| pubmed-article:18949722 | pubmed:meshHeading | pubmed-meshheading:18949722... | lld:pubmed |
| pubmed-article:18949722 | pubmed:meshHeading | pubmed-meshheading:18949722... | lld:pubmed |
| pubmed-article:18949722 | pubmed:meshHeading | pubmed-meshheading:18949722... | lld:pubmed |
| pubmed-article:18949722 | pubmed:meshHeading | pubmed-meshheading:18949722... | lld:pubmed |
| pubmed-article:18949722 | pubmed:meshHeading | pubmed-meshheading:18949722... | lld:pubmed |
| pubmed-article:18949722 | pubmed:articleTitle | Renin-angiotensin system blockade and contrast-induced renal toxicity. | lld:pubmed |
| pubmed-article:18949722 | pubmed:affiliation | Division of Nephrology, University Hospitals of Geneva, Geneva - Switzerland. Patrick.Saudan@hcuge.ch | lld:pubmed |
| pubmed-article:18949722 | pubmed:publicationType | Journal Article | lld:pubmed |
